logo

For the Inventor, By the Inventor

Aachen, Germany

Gruenenthal Gmbh


USPTO Granted Patents = 357



Forward Citations = 2,743

Loading Chart...
Loading Chart...

339 inventors (with patents filed for the assignee):

goldMedal Bernd Sundermann (79 out of 82 patents)

silverMedal Werner Guenter Englberger (50 out of 58 patents)

bronzeMedal Klaus Schiene (47 out of 56 patents)

4.  Hagen-Heinrich Hennies (38 out of 39 patents)

5.  Babette-Yvonne Koegel (37 out of 40 patents)

6.  Gregor Bahrenberg (36 out of 46 patents)

7.  Stefan Oberboersch (34 out of 35 patents)

8.  Thomas Christoph (33 out of 37 patents)

9.  Robert Frank (30 out of 30 patents)

10.  Ruth Jostock (29 out of 34 patents)

11.  Corinna Sundermann (28 out of 31 patents)

12.  Elmar Josef Friderichs (28 out of 32 patents)

13.  Klaus Linz (27 out of 35 patents)

14.  Hans Schick (26 out of 36 patents)

15.  Beatrix Merla (25 out of 26 patents)


Core Competencies:
Pyrrolidine Amides
Tapentadol Formulation
Pharmaceutical Composition
Transdermal Administration
Pain Management
Tamper-Resistant Dosage Forms
Azaspiro Compounds
Pyrimidine Derivatives
Analgesic Combinations
Electric-Field Assisted Administration
Vanilloid Receptor Ligands
Chronic Pain Treatment

357 patents:

1. 12344605 - Substituted pyrrolidine amides II (2025-07-01),
2. 12331034 - Substituted pyrrolidine amides V (2025-06-17),
3. 11547678 - Aqueous pharmaceutical formulation of tapentadol for oral administration (2023-01-10),
4. 11007156 - Prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol (2021-05-18),
5. 10898452 - Stable formulation for parenteral administration of Tapentadol (2021-01-26),
6. 10829480 - 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-l,3-diaza-spiro-[4.5]-decane derivatives (2020-11-10),
7. 10793556 - 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives (2020-10-06),
8. 10765848 - Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ (2020-09-08),
9. 10632195 - Pharmaceutical device for electric-field assisted administration of Tapentadol and method of administering Tapentadol with same (2020-04-28),
10. 10626106 - Substituted pyrrolidine amides I (2020-04-21),
11. 10471079 - Combination of selected analgesics and COX-II inhibitors (2019-11-12),
12. 10398657 - Method of inhibiting chronification of pain (2019-09-03),
13. 10391099 - Method of treating psoriatic arthritis, psoriasis, and chronic obstructive pulmonary disease with a novel 2,5-substituted pyrimidines (2019-08-27),
14. 10363228 - Transdermal administration of memantine (2019-07-30),
15. 10328055 - Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indo]-4-amine and antidepressants (2019-06-25),
Grunenthal is a pharmaceutical company that specializes in pain management and related therapies. With a history dating back to 1946, the company has become a leading global player in the field. They are dedicated to researching, developing, and providing innovative treatments that improve the quality of life for patients suffering from pain and other health conditions. Grunenthal's mission is to transform patients' lives by delivering effective and safe pain solutions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
357 Patents

#1 in Aachen

#174 in Germany

#2,487 in the World

...
Aachen, Germany

Gruenenthal Gmbh

Forward Citations = 2,743

339 inventors:

goldMedal Bernd Sundermann (79 out of 82 patents)

silverMedal Werner Guenter Englberger (50 out of 58 patents)

bronzeMedal Klaus Schiene (47 out of 56 patents)

4.  Hagen-Heinrich Hennies (38 out of 39 patents)

5.  Babette-Yvonne Koegel (37 out of 40 patents)

Please report any incorrect information to support@idiyas.com
Loading…